Riale Gilligan

Senior Scientist at NextPoint Therapeutics, Inc.

Riale Gilligan is a Senior Scientist at NextPoint Therapeutics, Inc. since March 2022, having previously held roles as a Scientist within the same organization. Prior experience includes a Graduate Student Co-op at Cocoon Biotech and a Protein Chemistry/CMC Co-op at Surface Oncology, where Riale Gilligan characterized antibody degradation mechanisms and developed clinical bioassay methods. Earlier experience includes a Medical Chemistry Co-op at Wave Life Sciences, focusing on the synthesis of stereopure amidites and conducting various analytical tests. Riale Gilligan holds a Master's degree in Bioengineering from Tufts University and a Bachelor's degree in Chemical Engineering and Physics from Northeastern University.

Location

Boston, United States

Links


Org chart

No direct reports

Teams


Offices


NextPoint Therapeutics, Inc.

NextPoint Therapeutics develops medications to expand the benefit of immunotherapies to cancer patients. The company offers immunotherapies for a validated checkpoint axis that is independent of PD-1/L1 and modulates both adaptive and innate immune systems to find and destroy cancer cells.


Employees

11-50

Links